Skip to main content
. 2022 Jun 27;119(27):e2203820119. doi: 10.1073/pnas.2203820119

Fig. 3.

Fig. 3.

Hematologic toxicity is either absent or transient in 177Lu-DTPA-SC16–treated mice with NEPC tumors. WBC counts (A), RBC counts (B), and PLT counts (C) in H660-bearing mice that received 177Lu-DTPA-SC16 treatment. Three of the 20 parameters measured are shown. Gray shading indicates the mean ± 1 SD of values collected from the entire cohort of H660-bearing mice prior to therapy initiation (week 0).